RAB8A a new biomarker for endometrial cancer?
Tóm tắt
We aimed to find different proteins between dendritic cells (DCs) and tumor antigen-pulsed DCs to help find a new biomarker for endometrial cancer (EC). Mononuclear cells were isolated from cord blood and induced to DCs by cytokines. A comparative proteomic analysis was performed on DCs and tumor lysate-pulsed DCs by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Differential proteins were identified by Western blot analysis. The expression of Ras-related protein Rab-8A (RAB8A) was found to be different in the in two kinds of cells. This phenomenon was also proven in endometrial cancer tissues. RAB8A might be a new biomarker for endometrial cancer. Using LC-MS/MS to perform a comparative proteomic analysis about DCs and tumor lysate-pulsed DCs may help us to find new biomarker of cancer.
Tài liệu tham khảo
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 2006, 56: 106-130. 10.3322/canjclin.56.2.106.
Kawakami Y, Fujita T, Matsuzaki Y, Sakurai T, Tsukamoto M, Toda M, Sumimoto H: Identification of human tumor antigens and its implications for diagnosis and treatment of cancer. Cancer Sci. 2004, 95: 784-791. 10.1111/j.1349-7006.2004.tb02182.x.
Schuler G, Schuler-Thurner B, Steinman RM: The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol. 2003, 15: 138-147. 10.1016/S0952-7915(03)00015-3.
Alaniz L, Rizzo MM, Mazzolini G: Pulsing dendritic cells with whole tumor cell lysates. Methods Mol Biol. 2014, 1139: 27-31. 10.1007/978-1-4939-0345-0_3.
Com E, Evrard B, Roepstorff P, Aubry F, Pineau C: New insights into the rat spermatogonial proteome: identification of 156 additional proteins. Mol Cell Proteomics. 2003, 2: 248-261.
Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999, 20: 3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2.
Keller A, Nesvizhskii AI, Kolker E, Aebersold R: Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002, 74: 5383-5392. 10.1021/ac025747h.
Steinman RM, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973, 137: 1142-1162. 10.1084/jem.137.5.1142.
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol. 2000, 18: 767-811. 10.1146/annurev.immunol.18.1.767.
Zhu Y, Liu C, Tummala R, Nadiminty N, Lou W, Gao AC: RhoGDIalpha downregulates androgen receptor signaling in prostate cancer cells. Prostate. 2013, 73: 1614-1622.
Sakao K, Hahm ER, Singh SV: In vitro and in vivo effects of phenethyl isothiocyanate treatment on vimentin protein expression in cancer cells. Nutr Cancer. 2013, 65 (Suppl 1): 61-67.
Jensen SS, Aaberg-Jessen C, Christensen KG, Kristensen B: Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas. Int J Clin Exp Pathol. 2013, 6: 1294-1305.
Rong F, Li W, Chen K, Li DM, Duan WM, Feng YZ, Li F, Zhou XW, Fan SJ, Liu Y, Tao M: Knockdown of RhoGDIalpha induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel. Neoplasma. 2012, 59: 541-550. 10.4149/neo_2012_070.
Albrecht C, Huck V, Wehling M, Wendler A: In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1. Steroids. 2012, 77: 1543-1550. 10.1016/j.steroids.2012.09.006.
Liao CL, Hsu JD, Lee MY, Kok LF, Li YJ, Wang PH, Yao CC, Han CP: Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?. Virchows Arch. 2010, 456: 377-386. 10.1007/s00428-010-0892-x.
Ang AL, Taguchi T, Francis S, Folsch H, Murrells LJ, Pypaert M, Warren G, Mellman I: Recycling endosomes can serve as intermediates during transport from the Golgi to the plasma membrane of MDCK cells. J Cell Biol. 2004, 167: 531-543. 10.1083/jcb.200408165.
Wiesner C, El Azzouzi K, Linder S: A specific subset of RabGTPases controls cell surface exposure of MT1-MMP, extracellular matrix degradation and three-dimensional invasion of macrophages. J Cell Sci. 2013, 126: 2820-2833. 10.1242/jcs.122358.
Agola JO, Jim PA, Ward HH, Basuray S, Wandinger-Ness A: Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet. 2011, 80: 305-318. 10.1111/j.1399-0004.2011.01724.x.
Shen DW, Gottesman MM: RAB8 enhances TMEM205-mediated cisplatin resistance. Pharm Res. 2012, 29: 643-650. 10.1007/s11095-011-0562-y.
Sun Y, Bilan PJ, Liu Z, Klip A: Rab8A and Rab13 are activated by insulin and regulate GLUT4 translocation in muscle cells. Proc Natl Acad Sci U S A. 2010, 107: 19909-19914. 10.1073/pnas.1009523107.